Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Bonfrer

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Cancer|October 1, 1988
Tamoxifen, serum lipoproteins and cardiovascular riskP F Bruning, J M Bonfrer, A A Hart, et al.
Cancer|September 1, 1995
Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancerK N Gaarenstroom, J M Bonfrer, G G Kenter, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 1, 2007
S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening. A comparison with liver function testsG S Missotten, C M Korse, C van Dehn, et al.
Photochemistry and Photobiology|March 25, 2000
Monitoring of impending myocardial damage after pleuropneumonectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma using biochemical markersJ M Klaase, J C Swaanenburg, H Schouwink, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2005
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical useM J Duffy, J M Bonfrer, J Kulpa, et al.
Gynecologic Oncology|December 1, 1994
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancerJ M Bonfrer, K N Gaarenstroom, G G Kenter, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancerP F Bruning, J M Bonfrer, A A Hart, et al.
Gynecologic Oncology|March 31, 2000
Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?K N Gaarenstroom, G G Kenter, J M Bonfrer, et al.
American Journal of Epidemiology|June 1, 1997
Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal womenA Zeleniuch-Jacquotte, P F Bruning, J M Bonfrer, et al.
Annals of Surgical Oncology|January 1, 1997
Value of laboratory tests in monitoring acute regional toxicity after isolated limb perfusionB C Vrouenraets, B B Kroon, J M Klaase, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Cancer|October 1, 1988
Tamoxifen, serum lipoproteins and cardiovascular riskP F Bruning, J M Bonfrer, A A Hart, et al.
Cancer|September 1, 1995
Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancerK N Gaarenstroom, J M Bonfrer, G G Kenter, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 1, 2007
S-100B protein and melanoma inhibitory activity protein in uveal melanoma screening. A comparison with liver function testsG S Missotten, C M Korse, C van Dehn, et al.
Photochemistry and Photobiology|March 25, 2000
Monitoring of impending myocardial damage after pleuropneumonectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma using biochemical markersJ M Klaase, J C Swaanenburg, H Schouwink, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 22, 2005
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical useM J Duffy, J M Bonfrer, J Kulpa, et al.
Gynecologic Oncology|December 1, 1994
Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancerJ M Bonfrer, K N Gaarenstroom, G G Kenter, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1989
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancerP F Bruning, J M Bonfrer, A A Hart, et al.
Gynecologic Oncology|March 31, 2000
Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?K N Gaarenstroom, G G Kenter, J M Bonfrer, et al.
American Journal of Epidemiology|June 1, 1997
Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal womenA Zeleniuch-Jacquotte, P F Bruning, J M Bonfrer, et al.
Annals of Surgical Oncology|January 1, 1997
Value of laboratory tests in monitoring acute regional toxicity after isolated limb perfusionB C Vrouenraets, B B Kroon, J M Klaase, et al.
Pageof 5